GI Dynamics to Provide Shareholder Update on 2017 Second Quarter Results

Aug 14, 2017 | Events

August 14, 2017 06:00 PM EDT

Webcast Presentation

Supporting Materials

Press Releases

11/27

GI Dynamics Announces Agreement with Apollo Sugar to Study EndoBarrier in India

Trial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity. BOSTON, SYDNEY, HYDERABAD,...

11/16

GI Dynamics Announces Close of Second Tranche of Placement and Grant of Options to CEO

BOSTON and SYDNEY — 16 November 2018 — GI Dynamics®, Inc. (ASX:GID), a medical device company that is developing...

10/31

GI Dynamics Announces Results of Special Meeting

BOSTON and SYDNEY — 1 November 2018 — GI Dynamics, Inc. (ASX:GID), a medical device company that is developing...